American Healthcare REIT Inc. Common Stock (AHR)

FairStock Score: 44/100 — MIXED

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I look at American Healthcare REIT as a turnaround story. FairStock labels it a TURNAROUND, returned to profit after a loss within the last three years, and the filed numbers support that: fiscal year 2023 revenue was $1.7B with a net loss of $71.5M, fiscal year 2024 revenue was $1.9B with a net loss of $37.8M, and fiscal year 2025 revenue was $2.1B with net income of $69.8M. In fiscal Q2 2026, the quarter ended 2026-06-30, revenue was $634.5M and net income was $30.6M, or $0.16 diluted EPS, versus revenue of $501.3M, net income of $9.9M, and $0.06 diluted EPS in fiscal Q2 2025. So the trend is real. But quality is only fair. This is capital-intensive healthcare real estate, and the data do not give me FFO or AFFO, the right REIT measures. I lean instead on dividend yield, leverage, revenue trend, and price-to-book. At the 2026-10-13 close of $52.53, FairStock shows P/B 2.77, dividend yield 1.92%, FCF yield 1.7%, and EV/EBITDA 28.19; those are not cheap. D/E 0.42 and Altman Z 3.16 suggest reasonable solvency, while ROE 3.95% and ROCE 2.10% show weak returns on capital. Piotroski 8/9 is a positive sign. Healthcare demand is durable, but I see no proven wide moat from these figures; capital intensity and cost of capital matter. My conclusion: improving operations, but the price already reflects much of the recovery, and without FFO/AFFO I cannot underwrite the dividend or valuation as a classic REIT bargain.

In plain English: American Healthcare REIT owns and operates healthcare buildings in the U.S., U.K., and Isle of Man, including senior housing, skilled nursing, and medical offices. The business is growing revenue and has returned to profit after losses, but profits are still thin and the stock looks expensive compared with those profits and the value of its net assets.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q2 2026 10-Q (period ended 2026-06-30) · fiscal Q1 2026 10-Q (period ended 2026-03-31) · fiscal Q3 2025 10-Q (period ended 2025-09-30) · fiscal Q2 2025 10-Q (period ended 2025-06-30) · FY2025 10-K (period ended 2025-12-31) · FY2024 10-K (period ended 2024-12-31) · FY2023 10-K (period ended 2023-12-31)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer